Biohaven Pharmaceuticals Inc is a pharmaceutical company based in New Haven, CT, that is dedicated to developing and delivering innovative therapies for patients with neurological and neuropsychiatric diseases. With a patient-first culture, Biohaven's team of skilled professionals is committed to challenging the status quo and advancing novel treatments to address unmet medical needs.
Driven by scientific innovation, Biohaven has a proven track record of bringing best-in-class therapies to market, including Nurtec ODT rimegepant, the first and only therapy that both treats and prevents migraine attacks. With an extensive portfolio across 20 therapeutic indications, Biohaven is focused on filling the treatment gaps for millions of people worldwide, including those with rare disorders, and is dedicated to creating a better future for patients through its pipeline of product candidates.
Generated from the website